Olaquindox metabolite Competitive Antibody Pair

AccuSift
MQCA
SKU Name Unit Price Delivery QTY
SE110 Olaquindox metabolite monoclonal antibody 1mg $667.6 10days
TA091 Olaquindox metabolite BSA antigen 1mg $266.6 10days
AccuSift provides high-performance 3-Methylquinoxaline-2-carboxylic acid (MQCA) competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.

3-Methylquinoxaline-2-carboxylic acid (MQCA) is the primary metabolite of Olaquindox in animals, serving as a marker residue for monitoring Olaquindox residues. MQCA features a quinoxaline ring core with a carboxyl group at the 2-position and a methyl group at the 3-position. Compared to the parent drug, MQCA has a longer residual period in animal tissues, making it more suitable for regulatory monitoring. Olaquindox and its metabolites possess cumulative toxicity, genotoxicity, and teratogenic risks, leading to their prohibition in food-producing animals in China.
Performance Characteristics:

  • Sensitivity: ELISA IC50: 1 ppb; Colloidal Gold: 0.5-1 ppb

  • Source: Mouse Monoclonal Antibody

  • Purity: ≥ 90%

  • Recommended Pairing: (Coating) / (Labeling)

  • Storage: Long-term storage at ≤ –20°C; short-term storage at 2–8°C. Shipped on ice packs.


Operation

References